Ocrelizumab Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 300 mg
Reference Brands: Ocrevus(EU & US)
Category:
Multiple sclerosis
Ocrelizumab is a monoclonal antibody that targets CD20-positive B-cells, reducing inflammation and immune attack in multiple sclerosis. It decreases relapse rates, slows disease progression, and reduces lesion activity. Benefits include improved neurological function, fewer relapses, and better quality of life for MS patients, with infusions every six months.
Ocrelizumab injection is available in Injection
and strengths such as 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ocrelizumab injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ocrelizumab injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ocrelizumab, marketed as Ocrevus, is approved in the US by the FDA and in the EU via EMA for relapsing and primary progressive multiple sclerosis. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing processes, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial results and manufacturing standards, while the EMA ensures regional safety and quality compliance.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing